Recent discussions on X about Tenet Healthcare Corporation (THC) have centered around the company’s performance and strategic moves in the healthcare sector. Many users have highlighted the stock’s potential for growth amid rising demand for hospital services, with some pointing to recent quarterly results as a sign of strength. The tone of these conversations often reflects optimism about the company’s ability to navigate industry challenges.
However, there are also concerns being voiced on the platform regarding broader market conditions and regulatory pressures that could impact THC’s future. Some users have debated the sustainability of recent gains, noting potential risks tied to healthcare policy changes. These mixed perspectives create a dynamic dialogue around the stock’s trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Tenet Healthcare Corporation Congressional Stock Trading
Members of Congress have traded $THC stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Tenet Healthcare Corporation Insider Trading Activity
Tenet Healthcare Corporation insiders have traded $THC stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- JAMES L BIERMAN has made 0 purchases and 4 sales selling 20,000 shares for an estimated $3,249,258.
- PAOLA M ARBOUR (EVP, Chief Information Officer) has made 0 purchases and 2 sales selling 14,199 shares for an estimated $2,373,726.
- J ROBERT KERREY has made 0 purchases and 9 sales selling 15,748 shares for an estimated $2,138,986.
- THOMAS W ARNST (EVP, Chief Admin. Officer & GC) sold 9,786 shares for an estimated $1,624,476
- LISA Y FOO (EVP, Chief Operating Officer) sold 8,000 shares for an estimated $1,436,240
- CHRISTOPHER S. LYNCH sold 3,952 shares for an estimated $697,093
- RICHARD W FISHER has made 0 purchases and 2 sales selling 3,913 shares for an estimated $654,682.
- CECIL D HANEY sold 2,500 shares for an estimated $310,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Tenet Healthcare Corporation Hedge Fund Activity
We have seen 308 institutional investors add shares of Tenet Healthcare Corporation stock to their portfolio, and 369 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 1,364,955 shares (-32.7%) from their portfolio in Q2 2025, for an estimated $240,232,080
- BOSTON PARTNERS added 1,095,630 shares (+94.2%) to their portfolio in Q2 2025, for an estimated $192,830,880
- NUVEEN, LLC removed 932,271 shares (-57.4%) from their portfolio in Q2 2025, for an estimated $164,079,696
- ALLIANCEBERNSTEIN L.P. added 624,125 shares (+375.7%) to their portfolio in Q2 2025, for an estimated $109,846,000
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 607,637 shares (-51.1%) from their portfolio in Q2 2025, for an estimated $106,944,112
- PACER ADVISORS, INC. added 590,028 shares (+inf%) to their portfolio in Q2 2025, for an estimated $103,844,928
- HOLOCENE ADVISORS, LP added 584,404 shares (+inf%) to their portfolio in Q2 2025, for an estimated $102,855,104
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Tenet Healthcare Corporation Government Contracts
We have seen $81,120 of award payments to $THC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STERILE PROCESSING SERVICES: $45,000
- INSTRUMENT STERILIZATION: $36,120
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Tenet Healthcare Corporation Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/14/2025
- Barclays issued a "Overweight" rating on 07/24/2025
- UBS issued a "Buy" rating on 07/23/2025
- Raymond James issued a "Outperform" rating on 07/23/2025
- Guggenheim issued a "Buy" rating on 07/23/2025
- Truist Securities issued a "Buy" rating on 07/16/2025
- Mizuho issued a "Outperform" rating on 07/11/2025
To track analyst ratings and price targets for Tenet Healthcare Corporation, check out Quiver Quantitative's $THC forecast page.
Tenet Healthcare Corporation Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $200.0 on 08/14/2025
- Benjamin Rossi from JP Morgan set a target price of $200.0 on 08/04/2025
- Michael Ha from Baird set a target price of $167.0 on 07/25/2025
- Andrew Mok from Barclays set a target price of $208.0 on 07/24/2025
- Jason Cassorla from Guggenheim set a target price of $188.0 on 07/23/2025
- John Ransom from Raymond James set a target price of $200.0 on 07/23/2025
- A.J. Rice from UBS set a target price of $238.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
